C/EBPα Is Critical for the Neonatal Acute-Phase Response to Inflammation

ABSTRACT

Members of the C/EBP (CCAAT/enhancer binding protein) family of transcription factors play important roles in mediating the acute-phase response (APR), an inflammatory process resulting from infection and/or tissue damage. Among the C/EBP family of proteins, C/EBPβ and -δ were thought to be the primary mediators of the APR. The function of C/EBPα in the APR has not been fully characterized to date. Here, we investigate the role of C/EBPα in the APR by using neonatal mice that lack C/EBPα expression. Northern blot analysis of acute-phase protein gene expression in neonatal mice treated with purified bacterial lipopolysaccharide or recombinant interleukin 1β as an inflammation stimulus showed a strong APR in wild-type mice, but a response in C/EBPα null animals was completely lacking. The C/EBPα knockout and wild-type mice demonstrated elevations in C/EBPβ and -δ mRNA expression and DNA binding as well as increased DNA binding of NF-κB, all of which are known to be important in the APR. Null mice, however, failed to activate STAT3 binding in response to lipopolysaccharide. Our results provide the first evidence that C/EBPα is absolutely required for the APR in neonatal mice, is involved in STAT3 regulation, and cannot be compensated for by other C/EBP family members.

ACKNOWLEDGMENTS

We thank the members of the Darlington lab for their support and encouragement throughout these studies. Recombinant human IL-1β was a gift from the National Cancer Institute. C/EBPβ knockout and heterozygous breeding mice were generously provided by Valeria Poli.

This work was supported by the National Institutes of Health (grants DK45285, AG13663, DK53045, T32-DK07664, and T32-GM08307) and the Moran Foundation.